The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
The total amount spent on HIV prevention research in 2013 dropped by 4 percent (US$50 million) to US$1.26 billion. Key reasons for this decline include a reduction in investments by the United States and European government donors and changes in the international development landscape. This is presented in a report from the HIV Vaccines and Microbicides Resource Tracking Working Group.
Last week The Lancet published a study which used a new systematic analysis method for the global, regional and national incidence and mortality for HIV, TB and Malaria. This study revealed that previous HIV mortality estimates have been hugely overestimated, and that the HIV epidemic is actually around 25 percent smaller than previously estimated, particularly across the concentrated epidemics of Latin America and Eastern Europe.